COPD patients’ self-reported adherence, psychosocial factors and mild cognitive impairment in pulmonary rehabilitation

International Journal of COPD

Volumn 12, Issue , 2017, Pages 2059-2067

  Pierobon, Antonia ^a   Bottelli, Elisa Sini ^a   Ranzini, Laura ^a   Bruschi, Claudio ^a   Maestri, Roberto ^a   Bertolotti, Giorgio ^a   Sommaruga, Marinella ^a   Torlaschi, Valeria ^a   Callegari, Simona ^a   Giardini, Anna ^a  

^a IRCCS   (Italy)

Author keywords

Adherence; Anxiety; COPD; Depression; Mild cognitive impairment; Pulmonary rehabilitation

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; BRONCHODILATING AGENT;

AGED; ANXIETY; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIET THERAPY; DIETARY COMPLIANCE; DISEASE SEVERITY; FAMILY RELATION; FEMALE; HUMAN; KINESIOTHERAPY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGY; OBSERVATIONAL STUDY; OXYGEN THERAPY; PATIENT COMPLIANCE; PULMONARY REHABILITATION; SELF REPORT; SIX MINUTE WALK TEST; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; ATTITUDE TO HEALTH; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DEMENTIA ASSESSMENT; ITALY; MENTAL HEALTH; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RESPIRATORY CARE; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME;

AGED; ANXIETY; BRONCHODILATOR AGENTS; CHI-SQUARE DISTRIBUTION; COGNITION; COGNITIVE DYSFUNCTION; COMBINED MODALITY THERAPY; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; EXERCISE THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MENTAL HEALTH; MENTAL STATUS AND DEMENTIA TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OXYGEN INHALATION THERAPY; PATIENT COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY; RISK FACTORS; SELF REPORT; SOCIAL SUPPORT; TREATMENT OUTCOME;

EID: 85026383620     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S133586     Document Type: Article

References (48)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2017). Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/. Accessed June 28, 2017.
2. Spruit MA, Singh SJ, Garvey C, et al; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–e64.
3. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;23(2):CD003793.
4. Nici L. Adherence to a pulmonary rehabilitation program: start by understanding the patient. COPD. 2012;9(5):445–446.
5. Bolton CE, Bevan-Smith EF, Blakey JD, et al; British Thoracic Society Pulmonary Rehabilitation Guideline Development Group; British Thoracic Society Standards of Care Committee. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013;68(Suppl 2): ii1–ii30.
6. Fan VS, Meek PM. Anxiety, depression, and cognitive impairment in patients with chronic respiratory disease. Clin Chest Med. 2014;35(2): 399–409.
7. Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014; (11):CD000011.
8. Cleutjens FAHM, Spruit MA, Ponds RWHM, et al. The impact of cognitive impairment on efficacy of pulmonary rehabilitation in patients with COPD. J Am Med Dir Assoc. 2017;18(5):420–426.
9. Selzler AM, Rodgers WM, Berry TR, Stickland MK. The importance of exercise self-efficacy for clinical outcomes in pulmonary rehabilitation. Rehabil Psychol. 2016;61(4):380–388.
10. Villeneuve S, Pepin V, Rahayel S, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012;142(6): 1516–1523.
11. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35(4):913–922.
12. Gudmundsson G, Gislason T, Janson C, et al. Depression, anxiety and health status after hospitalization for COPD: a multicenter study in the Nordic countries. Respir Med. 2006;100(1):87–93.
13. Eisner MD, Blanc PD, Yelin EH, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010;65(3):229–234.
14. Goodwin RD, Zvolensky MJ, Keyes KM. Nicotine dependence and mental disorders among adults in the USA: evaluating the role of mode of administration. Psychol Med. 2008;38(9):1277–1286.
15. Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospi-talisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26(3):414–419.
16. Xu W, Collet JP, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178(9):913–920.
17. Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009; 64(11):939–943.
18. Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107(10):1481–1490.
19. Wick JY. Long-term oxygen therapy: battling breathlessness. Consult Pharm. 2012;27(12):826–830.
20. Giardini A, Martin MT, Cahir C, et al. Toward appropriate criteria in medication adherence assessment in older persons: Position Paper. Aging Clin Exp Res. 2015;28(3):371–381.
21. Measso G, Cavarzeran F, Zappalà G, et al. The mini–mental state examination: normative study of an Italian random sample. Dev Neuropsychol. 1993;9(2):77–85.
22. Costantini M, Musso M, Viterbori P, et al. Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer. 1999;7(3): 121–127.
23. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49.
24. Ghisi M, Flebus GB, Montano A, Sanavio E, Sica C. BDI-II. Beck Depression Inventory – II. Firenze: Giunti O.S.; 2006.
25. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.
26. Majani G, Pierobon A, Giardini A, Callegari S. Valutare e favorire l’aderenza alle prescrizioni in riabilitazione cardiologica e pneumologica. [Screening and promoting the adherence in cardiological and pulmonary rehabilitation]. In: I Manuali della Fondazione Maugeri. Pavia: PI–ME; 2007. Italian.
27. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699.
28. Conti S, Bonazzi S, Laiacona M, Masina M, Coralli MV. Montreal Cognitive Assessment (MoCA)-Italian version: regression based norms end equivalent scores. Neurol Sci. 2015;36(2):209–214.
29. Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S467–S472.
30. Smarr KL, Keefer AL. Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Ques-tionnaire-9 (PHQ-9). Arthritis Care Res (Hoboken). 2011;63(Suppl 11): S454–S466.
31. Maurer J, Rebbapragada V, Borson S, et al; ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43S–56S.
32. Dulohery MM, Schroeder DR, Benzo RP. Cognitive function and living situation in COPD: is there a relationship with self-management and quality of life? Int J Chron Obstruct Pulmon Dis. 2015;10:1883–1889.
33. Uchmanowicz I, Jankowska-Polanska B, Motowidlo U, Uchmanowicz B, Chabowski M. Assessment of illness acceptance by patients with COPD and the prevalence of depression and anxiety in COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:963–970.
34. Stucki A, Stoll T, Cieza A, et al. ICF Core Sets for obstructive pulmonary diseases. J Rehabil Med. 2004;(Suppl 44):114–120.
35. Pierobon A, Giardini A, Callegari S, Majani G. Psychological adjustment to a chronic illness: the contribution from cognitive behavioural treatment in a rehabilitation setting. G Ital Med Lav Ergon. 2011;33(Suppl 1A): A11–A18.
36. de Sousa Pinto JM, Martín-Nogueras AM, Morano MT, Macêdo TE, Arenillas JI, Troosters T. Chronic obstructive pulmonary disease patients’ experience with pulmonary rehabilitation: a systematic review of qualitative research. Chron Respir Dis. 2013;10(3):141–157.
37. Almagro P, Castro A. Helping COPD patients change health behavior in order to improve their quality of life. Int J Chron Obstruct Pulmon Dis. 2013;8:335–345.
38. Schüz N, Walters JA, Cameron-Tucker H, Scott J, Wood-Baker R, Walters EH. Patient anxiety and depression moderate the effects of increased self-management knowledge on physical activity: a secondary analysis of a randomised controlled trial on health-mentoring in COPD. COPD. 2015;12(5):502–509.
39. Pierobon A, Giardini A, Majani G, et al. Into the cognitive constructs related to adherence to treatment in CHD outpatients: the importance of accepting the disease limitations. Monaldi Arch Chest Dis. 2009;72:130–138.
40. Park SK, Richardson CR, Holleman RG, Larson JL. Physical activity in people with COPD, using the National Health and Nutrition Evaluation Survey dataset. Heart Lung. 2013;42(4):235–240.
41. Hartman JE, Boezen HM, de Greef MH, Ten Hacken NH. Physical and psychological factors associated with physical activity in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2013;94(12):2396–2402.
42. Altenburg WA, Bossenbroek L, de Greef MH, Kerstjens HA, ten Hacken NH, Wempe JB. Functional and psychological variables both affect daily physical activity in COPD: a structural equations model. Respir Med. 2013;107(11):1740–1747.
43. Müllerová H, Landis SH, Aisanov Z, et al. Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey. Int J Chron Obstruct Pulmon Dis. 2016;11:881–890.
44. Costa E, Giardini A, Savin M, et al. Interventional tools to improve medication adherence: review of literature. Patient Prefer Adherence. 2015;9:1303–1314.
45. Ambrosino N, Clini EM. Response to pulmonary rehabilitation: toward personalised programmes? Eur Respir J. 2015;46(6):1538–1540.
46. Harrison SL, Goldstein R, Desveaux L, Tulloch V, Brooks D. Optimizing nonpharmacological management following an acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:1197–1205.
47. Bratås O, Espnes GA, Rannestad T, Walstad R. Characteristics of patients with chronic obstructive pulmonary disease choosing rehabilitation. J Rehabil Med. 2010;42(4):362–367.
48. Baldi S, Pinna GD, Bruschi C, et al. Medicinal clays improve the endurance of loaded inspiratory muscles in COPD: a randomized clinical trial of nonpharmacological treatment. Int J Chron Obstruct Pulmon Dis. 2015;10:2235–2248.